Seizure Management

Introduction to Seizure Management

Seizure management involves considering various factors, including medication tolerability, seizure history, and individual patient factors, as recommended by the American Academy of Neurology 1

The American Academy of Neurology recommends considering discontinuation of medication after 2 seizure-free years, taking into account individual patient factors, such as seizure history and medication tolerability 2, 1
A long seizure-free interval, such as 8 years, is a significant factor to consider when deciding to continue or withdraw antiseizure medication, as it may indicate a lower risk of seizure recurrence 3
Normal EEG findings and a normal neurological examination are also important considerations when evaluating the risk-benefit of withdrawing antiseizure medication 3
The potential benefits of withdrawing antiseizure medication include elimination of potential long-term medication side effects, improved quality of life without medication burden, reduced medication costs, and avoidance of potential drug interactions in the future 3
However, seizure recurrence is a significant risk, which could impact driving privileges, employment opportunities, overall quality of life, and risk of injury during a seizure 3

Valproic acid should be avoided in women with epilepsy if possible, according to the American Academy of Neurology 2
Folic acid supplementation is recommended for women on lamotrigine, as suggested by the American Academy of Neurology 2
Lamotrigine may be preferred over phenytoin or phenobarbital due to its lower risk of behavioral adverse effects, as recommended by the American Academy of Neurology 2
Non-enzyme-inducing antiepileptic drugs like lamotrigine are preferred to avoid interactions with other medications, as recommended by the American Society of Clinical Oncology 4
The American Diabetes Association notes that lamotrigine can cause gastrointestinal effects, including nausea, constipation, and dry mouth, as reported in a study published in 2011 5
Memory impairment is a recognized neurological side effect of lamotrigine therapy, and patients experiencing forgetfulness while taking lamotrigine should discuss possible approaches with their healthcare provider, including dose adjustment, timing of medication, ruling out other causes, and medication alternatives 6
Lamotrigine has a relatively favorable cognitive profile compared to many other antiepileptic medications, although the exact frequency of memory impairment with lamotrigine is difficult to estimate from available data 6, 3

The following medications can interact with lamotrigine:

Medication	Effect on Lamotrigine Levels
Enzyme inducers (e.g., carbamazepine, phenytoin)	Decrease
Valproate	Increase
Rifamycins (e.g., rifampin, rifabutin)	Decrease
Oral contraceptives	Decrease
Broad-spectrum antibiotics, antifungals, and antiparasitics	No significant interaction

7, 8, 9, 10

The American Academy of Neurology and the Centers for Disease Control and Prevention recommend monitoring lamotrigine serum levels in specific situations, such as treatment failure, breakthrough seizures, or when adding/removing interacting medications 7, 8
Monitoring is suggested 1-2 weeks after adding or removing interacting medications to maintain therapeutic efficacy and avoid toxicity 8, 9

The combination of antipsychotics and antidepressants, such as Vraylar and Cymbalta, can increase the risk of adverse effects, including QT prolongation and CNS depression 11
Additive sedative effects between Klonopin and other CNS depressants, such as Cymbalta, can cause excessive sedation 12
Regular clinical assessments, laboratory monitoring, ECG monitoring for QT prolongation, and therapeutic drug monitoring are essential when combining Cymbalta, Vraylar, Lamictal, and Klonopin 11
Monitoring for side effects, such as extrapyramidal symptoms, sedation, and cognitive effects, is crucial when combining these medications 11
The American Academy of Psychiatry recommends starting with lower doses of each medication and titrating slowly, especially lamotrigine, to avoid adverse effects 2
Avoiding this combination in patients with a history of cardiac conduction abnormalities, severe hepatic impairment, or history of adverse reactions to any of these medications is recommended 2

If withdrawal is chosen, gradual tapering over at least 4 weeks is recommended, with regular follow-up during and after the withdrawal period, and driving precautions should be discussed 13, 1
A seizure action plan should be provided, including clear instructions on what to do if seizures recur 13
Seizure recurrence risk is highest in the first year after discontinuation, and factors such as history of generalized seizures, prior difficulty achieving seizure control, and adult-onset epilepsy may increase this risk 13
Quality of life considerations should be central to the decision-making process, and the patient should understand that if seizures recur, resuming medication will be necessary, and the same level of seizure control may not be immediately achieved 13

Lamotrigine typically takes 4-6 weeks to reach therapeutic effectiveness due to the required slow titration schedule, with full therapeutic effect usually requiring maintenance dosage 14
The American Academy of Psychiatry recommends starting with lower doses of each medication and titrating slowly, especially lamotrigine, to avoid adverse effects 2